Cato Research (CATO), a full-service contract research organization (CRO) in its 25th year of global drug development success, and Cato BioVentures, CATO’s venture arm, proudly announce the opening of...
(PRWeb January 22, 2013)
Read the full story at http://www.prweb.com/releases/2013/1/prweb10346084.htm